BTIG Adds Amanda Murphy, CFA, as a Managing Director and Senior Biotechnology Equity Analyst
NEW YORK--(BUSINESS WIRE)--Oct 1, 2018-- announced today that Amanda Murphy, CFA, has joined the firm’s Research and Strategy division. As a senior equity research analyst focused on the biotechnology sector, Ms. Murphy specializes in gene therapy, gene editing and cell therapy for both burgeoning private and established public healthcare companies. Based in Chicago, she will report into David Lenchus, Director of Research at BTIG.
“Healthcare is a key focus area for the firm. Adding experienced professionals like Amanda solidifies our ability to assist institutional clients. As the sector becomes a larger part of the world economy, we are confident that she will provide relevant and actionable viewpoints, ” said Scott Kovalik, Co-Founder and Chief Executive Officer of BTIG.
Ms. Murphy joins BTIG as a Managing Director. Prior to BTIG, she was a Partner and Healthcare Analyst at William Blair & Company, focused on diagnostic services and life sciences. Previously, Ms. Murphy was a Business Analyst at Caremark and a Senior Consultant within the Strategy Consulting division at PricewaterhouseCoopers. She received a BS in biology from Boston College’s honors program, and an MBA in finance, accounting and economics from the Kellogg Graduate School of Management at Northwestern University.
“We are excited to welcome Amanda to BTIG,” commented Mr. Lenchus. “Our goal is to provide clients with differentiated thought leadership through our Healthcare Research. We believe Amanda’s innovative thinking and scientific analysis will better position clients focused on the gene therapy, gene editing and cell therapy space.”
BTIG Research and Strategy provides comprehensive fundamental research reports and in-depth industry and company observations for clients. Its sector focus includes consumer, energy, financials, healthcare, real estate, shipping, and technology, media and telecommunications.
For access to BTIG insights, visit www.btigresearch.com.
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005454/en/
Jill Gordon, 212.279.3115, ext. 226
Amanda Gold, 212.738.6134
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: PROFESSIONAL SERVICES BANKING CONSULTING FINANCE
SOURCE: BTIG, LLC
Copyright Business Wire 2018.
PUB: 10/01/2018 08:30 AM/DISC: 10/01/2018 08:31 AM